[18F]ACI-15916 PET in α-synucleinopathies
[18F]ACI-15916 PET in α-synucleinopathies
Recruiting · NCT06891703 · Registry updated 2025-11-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| [18F]ACI-15916 PET in α-synucleinopathies | Lewy body dementia, Parkinson disease, autonomic nervous system disorder, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, dementia, movement disorder, multiple system atrophy, nervous system disorder, neurodegenerative disease, parkinsonian disorder, primary dysautonomia, psychiatric disorder, synucleinopathy | Recruiting | Early phase 1 | 2025-11-19 | NCT06891703 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AC Immune SA | 5 |
| Karolinska Institutet | 493 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Karolinska Institutet | Solna | Sweden | 4 |